Boston Immune Technologies And Therapeutics Inc.
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $4.0Mattributed |
|---|---|
| Latest round | grant, $4.0M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | Winchester, Massachusetts |
| Industry | unknown |
| Stage | unknown |
| Website | bostonimmunetech.com |
Boston-based immunotherapy company developing antibody and immune-modulating programs in oncology. Built for licensing partners and clinical co-development. Targeting tumor-immune evasion mechanisms with proprietary candidates.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $4.0M | undisclosed |
Detected tech stack
Nginx, jQuery Migrate 3.4.1, Divi 4.27.4, WordPress, PHP, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $4.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $4.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | bostonimmunetech.com, read 2026-05-02 |
| Description | self-reported | bostonimmunetech.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.